People's Republic of telecommunications and information services business license 津ICP备13004463号-1 互联网药品信息服务资格（津）-非经营性-2018-0037
Import record of Italian powder inhaler is obtained successfully
18 Aug 2016 , Italian Plastiape S.p.A company’s powder inhaler was approved by China Food and Drug Administration. Greenpine as a agency obtained first-of-its-kind medical device registration certificate(NO.20161287).
As a powder suction tool, the product is mainly used for the treatment of lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), etc by the direct effect of drug on the lung. This product with CE certification was used for inhalation administration not only for bronchiectasis and corticosteroid medicine but also antiallergic and anti-inflammatory drugs more than 20 countries around the world.
As the sales and general agent of Plastiape in China, Greenpine would like to provide best product and service for clients with concept that “Offer safe and efficient products, make life healthier and better！”